Commonwealth Equity Services
XBI icon

Commonwealth Equity Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Commonwealth Equity Services’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
82,119
-2,572
-3% -$348K 0.02% 811
2026
Q1 		$10.8M Sell
84,691
-81,445
-49% -$10.2M 0.02% 857
2025
Q4 		$20.3M Buy
166,136
+42,776
+35% +$4.9M 0.03% 555
2025
Q3 		$12.4M Sell
123,360
-154
-0.1% -$13.9K 0.02% 810
2025
Q2 		$10.2M Sell
123,514
-13,845
-10% -$1.1M 0.01% 891
2025
Q1 		$11.1M Sell
137,359
-15,071
-10% -$1.35M 0.02% 806
2024
Q4 		$13.7M Buy
152,430
+39,190
+35% +$3.8M 0.02% 676
2024
Q3 		$11.2M Buy
113,240
+6,519
+6% +$640K 0.02% 772
2024
Q2 		$9.89M Sell
106,721
-7,171
-6% -$643K 0.02% 812
2024
Q1 		$10.8M Sell
113,892
-75,109
-40% -$6.97M 0.02% 756
2023
Q4 		$16.9M Sell
189,001
-6,032
-3% -$448K 0.03% 511
2023
Q3 		$14.2M Buy
195,033
+71,658
+58% +$5.72M 0.03% 540
2023
Q2 		$10.3M Sell
123,375
-5,260
-4% -$440K 0.02% 672
2023
Q1 		$9.8K Buy
128,635
+35,351
+38% +$2.93M 0.02% 679
2022
Q4 		$7.74M Sell
93,284
-7,275
-7% -$589K 0.02% 749
2022
Q3 		$7.98M Sell
100,559
-24,393
-20% -$2.06M 0.02% 669
2022
Q2 		$9.28M Buy
124,952
+23,379
+23% +$1.75M 0.02% 608
2022
Q1 		$9.13M Sell
101,573
-9,431
-8% -$871K 0.02% 653
2021
Q4 		$12.4M Buy
111,004
+17,401
+19% +$2.1M 0.03% 523
2021
Q3 		$11.8M Sell
93,603
-3,673
-4% -$473K 0.03% 515
2021
Q2 		$13.2M Sell
97,276
-49,158
-34% -$6.46M 0.03% 465
2021
Q1 		$19.9M Buy
146,434
+24,794
+20% +$3.71M 0.06% 325
2020
Q4 		$17.1M Buy
121,640
+4,396
+4% +$563K 0.05% 333
2020
Q3 		$13.1M Sell
117,244
-38,600
-25% -$4.33M 0.04% 359
2020
Q2 		$17.4M Buy
155,844
+32,467
+26% +$3.2M 0.07% 269
2020
Q1 		$9.55M Buy
123,377
+3,064
+3% +$271K 0.04% 361
2019
Q4 		$11.4M Sell
120,313
-19,120
-14% -$1.65M 0.04% 372
2019
Q3 		$10.6M Buy
139,433
+18,096
+15% +$1.5M 0.05% 368
2019
Q2 		$10.6M Buy
121,337
+17,509
+17% +$1.49M 0.05% 351
2019
Q1 		$9.4M Sell
103,828
-3,573
-3% -$304K 0.04% 374
2018
Q4 		$7.71M Buy
107,401
+6,314
+6% +$509K 0.04% 388
2018
Q3 		$9.69M Buy
101,087
+15,460
+18% +$1.5M 0.05% 356
2018
Q2 		$8.15M Sell
85,627
-33,099
-28% -$3.04M 0.04% 360
2018
Q1 		$10.4M Buy
118,726
+33,631
+40% +$3.07M 0.06% 289
2017
Q4 		$7.22M Buy
85,095
+16,589
+24% +$1.39M 0.04% 380
2017
Q3 		$5.93M Buy
68,506
+17,954
+36% +$1.44M 0.04% 391
2017
Q2 		$3.9M Sell
50,552
-3,558
-7% -$252K 0.02% 514
2017
Q1 		$3.75M Sell
54,110
-2,446
-4% -$164K 0.03% 518
2016
Q4 		$3.35M Buy
56,556
+12,030
+27% +$743K 0.02% 514
2016
Q3 		$2.95M Sell
44,526
-1,505
-3% -$93.1K 0.02% 528
2016
Q2 		$2.49M Buy
46,031
+8,742
+23% +$479K 0.02% 564
2016
Q1 		$1.93M Sell
37,289
-4,056
-10% -$211K 0.02% 655
2015
Q4 		$2.9M Sell
41,345
-153
-0.4% -$10.4K 0.03% 499
2015
Q3 		$2.58M Sell
41,498
-13,147
-24% -$1.04M 0.03% 499
2015
Q2 		$4.59M Buy
54,645
+8,337
+18% +$648K 0.05% 353
2015
Q1 		$3.48M Buy
46,308
+9,162
+25% +$640K 0.04% 428
2014
Q4 		$2.31M Buy
37,146
+2,961
+9% +$169K 0.03% 517
2014
Q3 		$1.78M Sell
34,185
-2,913
-8% -$149K 0.02% 602
2014
Q2 		$1.9M Sell
37,098
-3,798
-9% -$171K 0.02% 574
2014
Q1 		$1.94M Buy
40,896
+1,560
+4% +$79.9K 0.03% 529
2013
Q4 		$1.71M Sell
39,336
-8,469
-18% -$351K 0.02% 549
2013
Q3 		$2.06M Buy
47,805
+14,910
+45% +$604K 0.03% 441
2013
Q2 		$1.14M Buy
+32,895
New +$1.16M 0.02% 624

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

Commonwealth Equity Services's XBI Position: Q2 2026 in Review

Commonwealth Equity Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3% in Q2 2026, selling an estimated $348K and leaving 82,119 shares worth $13M. The position accounts for 0.02% of the portfolio, ranked #811.

Commonwealth Equity Services first reported a position in XBI in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.3M in Q4 2025. 349 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Commonwealth Equity Services held 82,119 shares of State Street SPDR S&P Biotech ETF worth $13M as of Q2 2026.
  • Commonwealth Equity Services sold 2,572 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $348K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Commonwealth Equity Services's portfolio in Q2 2026, its #811 holding.
  • Commonwealth Equity Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 53 quarters since.
  • Commonwealth Equity Services's State Street SPDR S&P Biotech ETF position peaked at $20.3M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.